These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22277275)

  • 1. Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver.
    Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Minor DR; Sze DY
    J Vasc Interv Radiol; 2012 Mar; 23(3):323-30.e1. PubMed ID: 22277275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of failure in colorectal patients with liver metastases after yttrium-90 radioembolization.
    Schonewolf CA; Patel B; Gensure RH; Narra V; Haffty BG; Nosher JL; Jabbour SK
    Am J Clin Oncol; 2014 Jun; 37(3):234-40. PubMed ID: 23275270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility Study.
    Kis B; Shridhar R; Mhaskar R; Gyano M; Frakes JM; El-Haddad G; Choi J; Kim RD; Hoffe SE
    J Vasc Interv Radiol; 2023 Sep; 34(9):1547-1555. PubMed ID: 37210030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases.
    Smits ML; van den Hoven AF; Rosenbaum CE; Zonnenberg BA; Lam MG; Nijsen JF; Koopman M; van den Bosch MA
    PLoS One; 2013; 8(7):e69448. PubMed ID: 23894481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis.
    Gonsalves CF; Eschelman DJ; Adamo RD; Anne PR; Orloff MM; Terai M; Hage AN; Yi M; Chervoneva I; Sato T
    Radiology; 2019 Oct; 293(1):223-231. PubMed ID: 31453767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity comparison of yttrium-90 resin and glass microspheres radioembolization.
    Braat MN; Braat AJ; Lam MG
    Q J Nucl Med Mol Imaging; 2024 Jun; 68(2):133-142. PubMed ID: 35762664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yttrium-90 Activity Quantification in PET/CT-Guided Biopsy Specimens from Colorectal Hepatic Metastases Immediately after Transarterial Radioembolization Using Micro-CT and Autoradiography.
    Naydenov N; Teplov A; Zirakchian MZ; Ruan S; Chu BP; Serencsits B; Iraca M; Talarico O; Miller B; Kunin H; Schwartz J; Kesner A; Furenlid LR; Dauer L; Yagi Y; Humm JL; Zanzonico P; Sofocleous CT; Kirov AS
    J Vasc Interv Radiol; 2023 Sep; 34(9):1556-1564.e4. PubMed ID: 37201655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of Radioembolization via the Cystic Artery in Patients with Hepatocellular Carcinoma and Parasitized Arterial Supply.
    Choi R; Lee M; Choi JW; Kim HC
    J Vasc Interv Radiol; 2023 Oct; 34(10):1802-1808. PubMed ID: 37364731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablative Radioembolization (SIRT) of a Large Inoperable Renal Cell Carcinoma Invading the Liver That Resulted in Hematuria Control and Complete Necrosis by mRECIST Criteria.
    Spyridonidis I; Dimopoulos P; Spyridonidis T; Christopoulou A; Katsanos K
    Clin Nucl Med; 2024 Jun; 49(6):557-558. PubMed ID: 38598452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAPM Medical Physics Practice Guideline 14.a: Yttrium-90 microsphere radioembolization.
    Busse NC; Al-Ghazi MSAL; Abi-Jaoudeh N; Alvarez D; Ayan AS; Chen E; Chuong MD; Dezarn WA; Enger SA; Graves SA; Hobbs RF; Jafari ME; Kim SP; Maughan NM; Polemi AM; Stickel JR
    J Appl Clin Med Phys; 2024 Feb; 25(2):e14157. PubMed ID: 37820316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases.
    Tsang ES; Loree JM; Davies JM; Gill S; Liu D; Ho S; Renouf DJ; Lim HJ; Kennecke HF
    Can J Gastroenterol Hepatol; 2020; 2020():5104082. PubMed ID: 33299824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial Radiation Nephrectomy Using 90 Y Resin Microspheres: A Treatment Option for Renal Tumors With Malignant Characteristics in Patients Not Candidates for Surgery.
    Sogbe M; Rodríguez-Fraile M; de la Cuesta AM; Rotellar F; Iñarrairaegui M
    Clin Nucl Med; 2023 Nov; 48(11):960-962. PubMed ID: 37756468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization: Is Prophylactic Embolization of Hepaticoenteric Arteries Necessary? A Systematic Review.
    Borggreve AS; Landman AJEMC; Vissers CMJ; De Jong CD; Lam MGEH; Monninkhof EM; Prince JF
    Cardiovasc Intervent Radiol; 2016 May; 39(5):696-704. PubMed ID: 26935724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver Metastases.
    Hamidi S; Mahvash A; Hu MI
    JCEM Case Rep; 2024 Aug; 2(8):luae103. PubMed ID: 39076377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer.
    Anbari Y; Veerman FE; Keane G; Braat AJAT; Smits MLJ; Bruijnen RCG; Tan W; Li Y; Duan F; Lam MGEH
    J Interv Med; 2023 Nov; 6(4):153-159. PubMed ID: 38312126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial Selective Internal Radiation Therapy with Yttrium-90 for Liver Metastatic Urothelial Carcinoma of the Ureter as a Bridging Therapy to Immunotherapy: A Case Report with a 10-Year Follow-Up.
    Schmid BP; Silva Cunha MJ; Moreira Valle LG; Galastri FL; Affonso BB; Falsarella PM; Kaliks Guendelmann RA; Garcia RG; Nasser F
    Case Rep Oncol; 2023; 16(1):711-717. PubMed ID: 37933309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable Outcomes Missing for Radiation Segmentectomy with Resin Microspheres.
    Malone CD; Sandow T
    J Vasc Interv Radiol; 2023 Oct; 34(10):1844-1846. PubMed ID: 37315682
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the Literature.
    Braat MNGJA; Ebbers SC; Alsultan AA; Neek AO; Bruijnen RCG; Smits MLJ; de Bruijne J; Lam MGEH; Braat AJAT
    Diagnostics (Basel); 2023 Dec; 13(24):. PubMed ID: 38132236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioembolization of renal cell carcinoma using yttrium-90 microspheres.
    Hamoui N; Gates VL; Gonzalez J; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2013 Feb; 24(2):298-300. PubMed ID: 23369565
    [No Abstract]   [Full Text] [Related]  

  • 20. Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma.
    Kis B; Shah J; Choi J; El-Haddad G; Sweeney J; Biebel B; Mellon E; Frakes JM; Hoffe SE; Fishman MN; Shridhar R
    J Vasc Interv Radiol; 2017 Feb; 28(2):254-259. PubMed ID: 27955832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.